Found: 10
Select item for more details and to access through your institution.
Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase-Dependent Apoptosis in Cerebral Ischemia/Reperfusion.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 3, p. 1, doi. 10.1002/ctm2.761
- By:
- Publication type:
- Article
SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.591
- By:
- Publication type:
- Article
Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α–sXBP1–GATA4 pathway.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 6, p. 1, doi. 10.1007/s00018-023-04805-9
- By:
- Publication type:
- Article
ADP-ribose transferase PARP16 mediated-unfolded protein response contributes to neuronal cell damage in cerebral ischemia/reperfusion.
- Published in:
- FASEB Journal, 2023, v. 37, n. 2, p. 1, doi. 10.1096/fj.202201426RR
- By:
- Publication type:
- Article
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 9, p. 1, doi. 10.1038/s41419-024-07053-2
- By:
- Publication type:
- Article
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 10, p. 1, doi. 10.1038/s41419-022-05321-7
- By:
- Publication type:
- Article
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41419-021-04365-5
- By:
- Publication type:
- Article
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00877-5
- By:
- Publication type:
- Article